LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value.Despite management's over-promising, LifeMD's telehealth and ...
Source LinkLifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value.Despite management's over-promising, LifeMD's telehealth and ...
Source Link
Comments